• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全甲状腺切除术后患者接受放射性碘(I-131)治疗后的唾液腺功能障碍:重点关注放射性碘治疗剂量。

Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.

作者信息

Lee Han Na, An Ji Young, Lee Kyung Mi, Kim Eui Jong, Choi Woo Suk, Kim Deog Yoon

机构信息

Department of Radiology, College of Medicine, Kyung Hee University, Seoul, Korea.

Department of Radiology, College of Medicine, Kyung Hee University, Seoul, Korea.

出版信息

Clin Imaging. 2015 May-Jun;39(3):396-400. doi: 10.1016/j.clinimag.2014.12.018. Epub 2015 Jan 7.

DOI:10.1016/j.clinimag.2014.12.018
PMID:25630229
Abstract

PURPOSE

The purpose of this study was to retrospectively evaluate symptoms, images of salivary gland dysfunction, and related clinical factors in thyroid cancer patients with total thyroidectomy followed by radioiodine therapy (RIT).

METHODS

We included 164 patients who underwent thyroid ultrasonography or contrast-enhanced neck computed tomography more than 6 months later after RIT. Correlation between subjective symptoms and various RIT doses was also evaluated.

RESULTS

Swelling and decreased salivary volume were the most common symptoms and images. RIT dose was the only factor with a positive correlation (P<.001).

CONCLUSION

The dose of RIT should be carefully determined to minimize gland dysfunction.

摘要

目的

本研究的目的是回顾性评估接受甲状腺全切术并随后进行放射性碘治疗(RIT)的甲状腺癌患者的症状、唾液腺功能障碍影像及相关临床因素。

方法

我们纳入了164例在RIT后6个月以上接受甲状腺超声检查或颈部增强计算机断层扫描的患者。还评估了主观症状与各种RIT剂量之间的相关性。

结果

肿胀和唾液量减少是最常见的症状和影像表现。RIT剂量是唯一具有正相关性的因素(P<0.001)。

结论

应谨慎确定RIT剂量,以尽量减少腺体功能障碍。

相似文献

1
Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.全甲状腺切除术后患者接受放射性碘(I-131)治疗后的唾液腺功能障碍:重点关注放射性碘治疗剂量。
Clin Imaging. 2015 May-Jun;39(3):396-400. doi: 10.1016/j.clinimag.2014.12.018. Epub 2015 Jan 7.
2
Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.使用非增强 CT 评估甲状腺癌放射性碘治疗后唾液腺功能障碍:腺体体积和密度变化的意义。
AJNR Am J Neuroradiol. 2012 Nov;33(10):1964-70. doi: 10.3174/ajnr.A3063. Epub 2012 May 3.
3
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.甲状腺癌患者放射性碘治疗后唾液腺功能的迟发副作用。
Head Neck. 2011 May;33(5):686-90. doi: 10.1002/hed.21520. Epub 2010 Nov 10.
4
Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.放射性碘治疗后甲状腺癌患者唾液腺功能障碍的闪烁显像评估
Clin Nucl Med. 2002 Nov;27(11):767-71. doi: 10.1097/00003072-200211000-00003.
5
Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.分化型甲状腺癌患者重组人生长激素预处理后放射性碘 remnant ablation 后唾液腺和泪腺功能障碍。
Thyroid. 2013 May;23(5):617-9. doi: 10.1089/thy.2012.0050. Epub 2013 Apr 18.
6
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?柠檬糖能否降低甲状腺癌放射性碘治疗后的唾液腺损伤?
J Nucl Med. 2005 Feb;46(2):261-6.
7
Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.利用唾液腺闪烁显像术对放射性碘治疗后唾液腺功能障碍进行定量评估。
Nucl Med Commun. 2006 Jun;27(6):495-9. doi: 10.1097/00006231-200606000-00004.
8
[Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].[分化型甲状腺癌患者¹³¹I治疗后唾液腺损伤。初步报告]
Endokrynol Pol. 2008 Sep-Oct;59(5):403-10.
9
Sialoendoscopic treatment for radioiodine induced sialadenitis.涎腺内镜治疗放射性碘诱发的涎腺炎。
Laryngoscope. 2007 Jan;117(1):133-6. doi: 10.1097/01.mlg.0000247776.72484.62.
10
Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.分化型甲状腺癌患者放射性碘消融后 5 年的唾液腺功能:消融前后闪烁显像的直接比较及其与口干症状的关系。
Thyroid. 2013 May;23(5):609-16. doi: 10.1089/thy.2012.0106. Epub 2013 Apr 18.

引用本文的文献

1
[Ga]Ga-FAPI-04 PET/CT in the evaluation of radiation-induced salivary gland injury in head and neck cancer.[镓]镓-FAPI-04 PET/CT在评估头颈部癌放射性唾液腺损伤中的应用
Eur J Nucl Med Mol Imaging. 2025 Aug 12. doi: 10.1007/s00259-025-07486-7.
2
The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review.放射性碘(¹³¹I)治疗甲状腺疾病对唾液腺功能和炎症的影响:综述
Biomedicines. 2025 Jun 7;13(6):1404. doi: 10.3390/biomedicines13061404.
3
Ultrasound and Sialendoscopy Findings in Radioactive Iodine-Induced Sialadenitis: Comparative Analysis and Possible Impact on Management.
放射性碘诱发涎腺炎的超声和涎腺内镜检查结果:对比分析及对治疗的可能影响
J Clin Med. 2024 Jan 23;13(3):657. doi: 10.3390/jcm13030657.
4
The effect of selenium supplementation on sonographic findings of salivary glands in papillary thyroid cancer (PTC) patients treated with radioactive iodine: study protocol for a double-blind, randomized, placebo-controlled clinical trial.硒补充剂对放射性碘治疗的甲状腺乳头癌(PTC)患者唾液腺超声表现的影响:一项双盲、随机、安慰剂对照临床试验研究方案。
Trials. 2023 Aug 7;24(1):501. doi: 10.1186/s13063-023-07470-2.
5
Optimal administration time of vitamin C after I therapy in differentiated thyroid cancer based on propensity score matching.基于倾向得分匹配的分化型甲状腺癌碘治疗后维生素C的最佳给药时间
Front Surg. 2022 Sep 22;9:993712. doi: 10.3389/fsurg.2022.993712. eCollection 2022.
6
Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.放射性碘治疗分化型甲状腺癌患者唾液腺功能障碍的预防:随机对照试验的系统评价。
Front Endocrinol (Lausanne). 2022 Aug 29;13:960265. doi: 10.3389/fendo.2022.960265. eCollection 2022.
7
Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?涎腺炎作为甲状腺癌患者放射性碘治疗的并发症:我们目前的情况如何?
Hormones (Athens). 2021 Dec;20(4):669-678. doi: 10.1007/s42000-021-00304-3. Epub 2021 Jun 18.
8
Sialographic Analysis of Radioiodine-Associated Chronic Sialadenitis.放射性碘相关慢性唾液腺炎的唾液腺造影分析。
Laryngoscope. 2021 May;131(5):E1450-E1456. doi: 10.1002/lary.29279. Epub 2020 Nov 17.
9
Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors.分化型甲状腺癌放射性碘治疗后的早期涎腺炎:患病率及预测因素
Int J Endocrinol. 2020 Aug 4;2020:8649794. doi: 10.1155/2020/8649794. eCollection 2020.
10
Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis.超声回声纹理可作为 131I 放射性碘治疗分化型甲状腺癌继发涎腺炎的替代指标:一项综述和荟萃分析。
Clinics (Sao Paulo). 2020 Oct 19;75:e1843. doi: 10.6061/clinics/2020/e1843. eCollection 2020.